Presented at OPT Congress 2023 by Gerard Platenburg - ProQR Therapeutics

 

Gerard Platenburg - Chief Scientific Officer and co-founder

Gerard is a co-founder and has served as our Chief Scientific Officer since 2022, following his tenure as Chief Innovation Officer from 2014 to 2022. Gerard has an extensive background in RNA modulation and orphan drug discovery and development and is currently in charge of our Innovation unit.

 

Gerard Platenburg